WHO ICTRP trial
A phase III clinical study to compare paclitaxel (Genexol®-PM) in combination…
KCT0003726 · Clinical Research Information Service (CRIS) · Not Recruiting
Key facts
| Trial ID | KCT0003726 |
|---|---|
| Public title | A phase III clinical study to compare paclitaxel (Genexol®-PM) in combination with standard therapy (gemcitabine/cisplatin) and standard therapy alone (gemcitabine/cisplatin) in patients with advanced biliary tract |
| Scientific title | A phase III clinical study to compare paclitaxel (Genexol®-PM) in combination with standard therapy (gemcitabine/cisplatin) and standard therapy alone (gemcitabine/cisplatin) in patients with advanced biliary tract cancer |
| Primary sponsor | Asan Medical Center |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Not Recruiting |
| Study type | Interventional Study |
| Phase | Phase3 |
| Countries | Korea, Republic of |
| Conditions | Neoplasms |
| Interventions | Drug : 1. Control arm gemcitabine plus cisplatin every 3 weeks, 9 cycles - Cisplatin IV 25mg/m2 D1, 8 - Gemcitabine IV 1,000 mg/m2 IV D1, 8 2. Experimental arm gemcitabine, cisplatin, and Genexol®PM every 3 weeks, 9 cycles - Genexol®PM IV… |
| Registration date | Apr 8, 2019 |
| Target size | 220 |
| Registry page | cris.nih.go.kr |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: